BEY-27012-29236
2 vaccinations
3 coded responses
24 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 547 / WI
- Registered
- 2022-08-11
- Relationship
- Child or adolescent in my care
- Guardian
- L5Z-10924-90030
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-11
Registered in v-safe
-
2022-08-11
Dose 1 — Pfizer-BioNTech
- 2022-08-11
- 2022-08-12
- 2022-08-13
- 2022-08-14
- 2022-08-15
- 2022-08-16
- 2022-08-17
- 2022-08-18
- 2022-08-25
-
2022-09-01
Dose 2 — Pfizer-BioNTech
- 2022-09-01
- 2022-09-02
- 2022-09-03
- 2022-09-04
- 2022-09-05
- 2022-09-06
- 2022-09-07
- 2022-09-08
-
2022-09-17
Survey response — day 14, dose 2, dependentMedDRA: Eye pruritus, Lacrimation increased, Nasal congestion, Productive cough, Rhinorrhoea — Feeling: FairFree text: Nasal congestion Runny nose Flemmy cough Itchy water eyesMedDRA releases: 2024-11 · check-in free text available
- 2022-09-22
- 2022-09-29
- 2022-10-06
-
2022-10-13
Survey response — day 42, dose 2, dependentMedDRA: Oropharyngeal pain, Productive cough, Rhinorrhoea, Sneezing, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Throwing up, sore throat, sneezing, runny nose and flemmy coughMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2023-03-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-11 | Pfizer-BioNTech | No |
| 2 | 2022-09-01 | Pfizer-BioNTech | No |
Free text
Release 12 — day 14, dose 2, dependent
Symptoms: Nasal congestion Runny nose Flemmy cough Itchy water eyes
Release 12 — day 42, dose 2, dependent
Symptoms: Throwing up, sore throat, sneezing, runny nose and flemmy cough
Release 12 — 3 months, dose 2, dependent
Symptoms: Runny nose and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release